Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· ARDDAudio: English

ARDD 2026 talk description: nutritional approaches to healthspan and GLP-1-related malnutrition

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

The description attributes to Philipp Gut (Nestlé) a talk at ARDD 2026 on nutritional approaches to healthspan, with the stated takeaway that weight loss lowers biological age while GLP-1 users face 'hidden malnutrition' needing targeted nutritional support. [1]

  1. The description attributes to Philipp Gut of Nestlé a talk at the 13th Aging Research and Drug Discovery Meeting titled 'Nutritional approaches to improve healthspan: from proactive care to therapeutic use'. [1]

  2. The description's stated key takeaway is that weight loss lowers biological age. [1]

  3. The same takeaway says GLP-1 users face 'hidden malnutrition' that calls for targeted nutritional support. [1]

Talk topic attributed to Gut at ARDD 2026

According to the description, Philipp Gut of Nestlé presented at the 13th Aging Research and Drug Discovery Meeting. The stated title is 'Nutritional approaches to improve healthspan: from proactive care to therapeutic use'. The description frames this as a talk on nutrition and healthspan, moving from proactive care toward therapeutic use. No methods, data or study design are given in the description. [1]

Stated takeaway on weight loss and biological age

The description lists one key takeaway: weight loss lowers biological age. It does not say how biological age was measured, in which people, over what period, or whether the observation comes from a study, a trial or general discussion. The description presents this as the speaker's takeaway, not as an established causal effect. [1]

Described 'hidden malnutrition' among GLP-1 users

The same takeaway states that GLP-1 users face 'hidden malnutrition' that calls for targeted nutritional support. The description does not define 'hidden malnutrition', name specific nutrients, give numbers, or describe how such support was tested. It also does not specify which GLP-1 medicines or which user group are meant. These points are attributed to the talk as summarized in the description. [1]

Context & limits

This is only the video description; the video and transcript were not reviewed. The description gives no study design, sample, measurement method, numbers or follow-up, and does not define 'hidden malnutrition' or name the GLP-1 medicines involved. All content is attributed to the description and the speaker it names.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] Philipp Gut at ARDD2026: Nutritional approaches to improve healthspan
Quoted passages in the original language
Nutritional approaches to improve healthspan: from proactive
Weight loss lowers biological age
GLP-1 users face “hidden malnutrition”

About this video

Creator description · original textText language: English

Philipp Gut, Nestlé, presents at the 13th Aging Research and Drug Discovery Meeting: Nutritional approaches to improve healthspan: from proactive care to therapeutic use Key takeaway: Weight loss lowers biological age, but GLP-1 users face “hidden malnutrition” that calls for targeted nutritional support. The Aging Research and Drug Discovery (ARDD) meeting is the world's leading conference dedicated to longevity biotechnology. It convenes top researchers, pharmaceutical executives, regulators, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines. ARDD was founded by Alex Zhavoronkov in 2014. Following years of growth in Europe, ARDD made its North American debut in Boston at the David Rubenstein Treehouse at Harvard University on October 1-3, 2026. The conference opened with a ribbon-cutting ceremony led by Admiral Brian Christine, US Assistant Secretary for Health, to commemorate its move to the US. Follow us for updates on ARDD 2027 in Boston! Website: https://agingpharma.org/ LinkedIn: https://www.linkedin.com/company/agingpharma/ ARDD 2026 was organized by @InsilicoMedicine with support from Eli Lilly, AstraZeneca, AbbVie, Novo Nordisk, Nestlé, XPRIZE Healthspan, Human Longevity, Dior, Maxwell Biosciences, Microsoft, BioAge, Gordian Biotechnology, GlycanAge, LongeVC, AniVC, Tolerance Bio, Tally Health, Institute for Healthier Living Abu Dhabi, TruDiagnostic, Cambrian Bio, ARTAN Bio, bio.xyz, Cyclarity Therapeutics, Rubedo Life Sciences, Biocytogen, SAISHO, Life Biosciences, Shift Bioscience, Synaro Capital, Biointron, The Cat Health Company, PranaGen Bioscience, Rhizome, Einstein BIO-VITAL Program, Alden Scientific, BDO, Cole-Frieman & Mallon, Morgan Stanley, Estée Lauder Companies, ICFSR, QuadraScope, BrainKey, Retro Biosciences, Compound Life, MobiDrop, Trilliome, and Nagi Bioscience. #ARDD2026 #longevity #aging #drugdiscovery

ARDD · 19 min · Source published: 2026-10-19

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…